Obesity
Not yet recruitingKAI-9531 in Adults With Obesity or Overweight and Diabetes
KAI-9531 in Adults With Obesity or Overweight and Diabetes
Germany- Participants:18–64 years · 65+ years
- Substances:HRS 9531
- Sponsor:Kailera Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany721 clinical trials in Freudenstadt, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)KAI-9531 in Adults With Obesity or Overweight and Diabetes
GermanyTesting GIA632 compared to placebo in adults with moderate to severe atopic dermatitis to measure effectiveness and safety
GermanyStudy of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
Germany
GermanyNeoadjuvant Study of Avelumab with Gemcitabine and Cisplatin versus Chemotherapy Alone in Patients with High‑Grade Localized Upper Tract Urothelial Carcinoma
FranceEfficacy and safety of intravitreal MK-8748 versus aflibercept in adults with diabetic macular edema
GermanySafety and Immunogenicity Study of IDH1 Peptide Vaccine and Vorasidenib in Adults with Recurrent IDH1R132H‑Mutant Astrocytoma (Grades 2‑4)
GermanyPhase 3 Randomized Study of RAP-219 to Reduce Seizure Frequency in Adults with Focal Epilepsy
GermanyEfficacy and safety of remibrutinib, pimecrolimus and tacrolimus in adults with severe chronic pruritus of unknown origin (CPUO): a randomized, placebo‑controlled trial
GermanyRandomized phase III study of AAA817 plus an androgen receptor pathway inhibitor in adult men with PSMA‑positive metastatic castration‑resistant prostate cancer
GermanyEfficacy and safety of GIA632 versus placebo in adults with moderate to severe cutaneous lichen planus
GermanyStudy of Sublingual Glyceryl Trinitrate Spray to Reduce Angina in Adults with Symptomatic Coronary Artery Disease
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical studies focusing on hormone receptor-positive HER2-negative breast cancer, exploring combination therapies with endocrine treatment approaches.
Research aims to evaluate treatment effectiveness and patient outcomes through systematic monitoring and assessment.
Groundbreaking research investigating advanced biliary tract cancers through combination therapy approaches using immunotherapy and chemotherapy.
The research focuses on evaluating novel treatment combinations to improve patient outcomes in advanced disease stages.
Tell us about your condition – we search every trial in Europe and connect you with the right site.